Cyclic AMP-Stimulated Interaction between Steroidogenic Factor 1 and Diacylglycerol Kinase θ Facilitates Induction of CYP17
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
In the human adrenal cortex, adrenocorticotropin (ACTH) activates CYP17 transcription by promoting the binding of the nuclear receptor steroidogenic factor 1 (SF1) (Ad4BP, NR5A1) to the promoter. We recently found that sphingosine is an antagonist for SF1 and inhibits cyclic AMP (cAMP)-dependent CYP17 gene transcription. The aim of the current study was to identify phospholipids that bind to SF1 and to characterize the mechanism by which ACTH/cAMP regulates the biosynthesis of this molecule(s). Using tandem mass spectrometry, we show that in H295R human adrenocortical cells, SF1 is bound to phosphatidic acid (PA). Activation of the ACTH/cAMP signal transduction cascade rapidly increases nuclear diacylglycerol kinase (DGK) activity and PA production. PA stimulates SF1-dependent transcription of CYP17 reporter plasmids, promotes coactivator recruitment, and induces the mRNA expression of CYP17 and several other steroidogenic genes. Inhibition of DGK activity attenuates the binding of SF1 to the CYP17 promoter, and silencing of DGK-theta expression inhibits cAMP-dependent CYP17 transcription. LXXLL motifs in DGK-theta mediate a direct interaction of SF1 with the kinase and may facilitate binding of PA to the receptor. We conclude that ACTH/cAMP stimulates PA production in the nucleus of H295R cells and that this increase in PA concentrations facilitates CYP17 induction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent work indicates that SF1 may activate human CYP17A1 expression in response to sphingosine (256,257).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [257]
Citations
Cites
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Luo, X., Ikeda, Y., & Parker, K. L. (1994) · Cell · doi:10.1016/0092-8674(94)90211-9 · Cited by 1,631
Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055
Nuclear speckles: a model for nuclear organelles
Lamond, A. I., & Spector, D. L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1172 · Cited by 1,000
Structure and specificity of nuclear receptor–coactivator interactions
Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J., & Yamamoto, K. R. (1998) · Genes & Development · doi:10.1101/gad.12.21.3343 · Cited by 924
Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H. (2005) · Endocrine Reviews · doi:10.1210/er.2002-0050 · Cited by 620
Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation
McInerney, E. M., Rose, D. W., Flynn, S. E., Westin, S., Mullen, T.-M., Krones, A., Inostroza, J., Torchia, J., Nolte, R. T., Assa-Munt, N., et al. (1998) · Genes & Development · doi:10.1101/gad.12.21.3357 · Cited by 613
The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis.
Ingraham, H. A., Lala, D. S., Ikeda, Y., Luo, X., Shen, W. H., Nachtigal, M. W., Abbud, R., Nilson, J. H., & Parker, K. L. (1994) · Genes & Development · doi:10.1101/gad.8.19.2302 · Cited by 602
Stocco, D. M., Wang, X., Jo, Y., & Manna, P. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0532 · Cited by 538
Krylova, I. N., Sablin, E. P., Moore, J., Xu, R. X., Waitt, G. M., MacKay, J. A., Juzumiene, D., Bynum, J. M., Madauss, K., Montana, V., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.024 · Cited by 404
Research works printed but not linked: 9
- Christensen L. K., 2001, Arch. Med. Res., 32, 1245
- Evangelisti C., 2006, Eur. J. Histochem., 50, 9
- Guo I. C., 2003, J. Biomed. Sci., 10, 593
- 10.1210/mend.13.9.0349 · doi:10.1210/mend.13.9.0349 · Paper page
- 10.1210/mend.15.1.0580 · doi:10.1210/mend.15.1.0580 · Paper page
- 10.1210/endo.143.5.8820 · doi:10.1210/endo.143.5.8820 · Paper page
- Staels B., 1993, Mol. Endocrinol., 7, 423
- Tu-Sekine B., 2004, Eur. J. Histochem., 48, 77
- Zhou D., 2000, Mol. Endocrinol., 14, 986
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Mostaghel, E. A., Marck, B. T., Plymate, S. R., Vessella, R. L., Balk, S., Matsumoto, A. M., Nelson, P. S., & Montgomery, R. B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0728 · Cited by 588
“CYP17A1 is regulated by SF-1 and other co-factors (31), and its regulatory domains contain multiple cAMP responsive elements, providing several targets for modulation of enzyme expression, such as using phosphodiesterase inhibitors (32).”
Nuclear speckles: molecular organization, biological function and role in disease
Galganski, L., Urbanek, M. O., & Krzyzosiak, W. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx759 · Cited by 499
“Taken together, these facts reinforce the view that NSs are nuclear hubs for PI production and signaling, which are important for protein targeting to NSs and NS assembly, as well as for the regulation of transcription, transcript maturation, splicing and export (26,27,55,58).”
BackgroundMinireview: steroidogenic factor 1: its roles in differentiation, development, and disease
Schimmer, B. P., & White, P. C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0519 · Cited by 268
“may be secondary to ligand activation of SF-1 (52) or to”
A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects
Lee, J. M., Lee, Y. K., Mamrosh, J. L., Busby, S. A., Griffin, P. R., Pathak, M. C., Ortlund, E. A., & Moore, D. D. (2011) · Nature · doi:10.1038/nature10111 · Cited by 247
Regulation and Functions of Diacylglycerol Kinases
Shulga, Y. V., Topham, M. K., & Epand, R. M. (2011) · Chemical Reviews · doi:10.1021/cr1004106 · Cited by 233
Steroidogenic Factor-1 (SF-1, Ad4BP, NR5A1) and Disorders of Testis Development
Lin, L., & Achermann, J. C. (2008) · Sexual Development · doi:10.1159/000152036 · Cited by 198
“, cAMP/ diacylglycerol kinase) [Krylova et al., 2005; Li et al., 2007].”
BackgroundRegulation of aldosterone synthesis and secretion.
Bollag, W. B. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130037 · Cited by 180
“Phosphatidic acid also binds to and regulates the transcriptional activity of steroidogenic factor-1 (SF-1), although the phosphatidic acid is reported to arise indirectly from diacylglycerol kinase-mediated phosphorylation of diacylglycerol rather than directly from PLD activity (and the gene affected is CYP17, encod…”
Molecular aspects of steroidogenic factor 1 (SF-1)
Hoivik, E. A., Lewis, A. E., Aumo, L., & Bakke, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.003 · Cited by 168
Blind, R. D., Suzawa, M., & Ingraham, H. A. (2012) · Science Signaling · doi:10.1126/scisignal.2003111 · Cited by 117
“Others have noted that silencing diacylglycerol (DAG) kinase q also reduces SF-1 activity and recruitment to target gene promoters (41).”
BackgroundPhosphatidic Acid-Mediated Signaling
Liu, Y., Su, Y., & Wang, X. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_9 · Cited by 118
Nuclear Sphingolipid Metabolism
Lucki, N. C., & Sewer, M. B. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153321 · Cited by 85
“SF-1 antagonist ligand Sphingosine-1-phosphate Chromatin Histone acetylation GM1 Inner nuclear membrane Ca2+ homeostasis GD3 ?”
BackgroundInfluentialSelf-citationPogrmic‐Majkic, K., Fa, S., Dakić, V., Kaišarević, S., & Kovačević, R. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp135 · Cited by 84
“Transcripts for luteinizing hormone receptor (LHR), scavenger receptor B1 (SR-B1), steroidogenic factor-1 (SF-1), steroidogenic acute regulatory protein (StAR), translocator protein (TSPO), phospodiesterase 4B (PDE4B) which participate in the cAMP-dependent control of steroidogenesis, as well as 3b-hydroxysteroid dehy…”
BackgroundInfluentialPogrmic‐Majkic, K., Fa, S., Dakić, V., Kaišarević, S., & Kovačević, R. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq227 · Cited by 78
“Progesterone-and Androstenedione-Supported Testosterone Production The results of gene expression demonstrated that CYP17A1 and 17bHSD were affected by 24 h in vitro atrazine exposure.”
InfluentialMultiple Roles for Sphingolipids in Steroid Hormone Biosynthesis
Lucki, N. C., & Sewer, M. B. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_15 · Cited by 86
“Notably, we have also demonstrated that phosphatidic acid (PA) is an endogenous activating ligand for SF1 in H295R adrenocortical cells (Li et al., 2007).”
BackgroundSelf-citationHedgehog Signaling and Steroidogenesis
Finco, I., LaPensee, C. R., Krill, K. T., & Hammer, G. D. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-061214-111754 · Cited by 76
Stanley, J. K., Perkins, E. J., Habib, T., Sims, J. G., Chappell, P., Escalon, B. L., Wilbanks, M. S., & García‐Reyero, N. (2013) · Environmental Science & Technology · doi:10.1021/es401115q · Cited by 66
Minireview: Steroidogenic Factor 1: Its Roles in Differentiation, Development, and Disease
Schimmer, B. P., & White, P. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.95.3.9994 · Cited by 66
Steroidogenic gene expression during sex determination in the frog Rana rugosa
Maruo, K., Suda, M., Yokoyama, S., Oshima, Y., & Nakamura, M. (2008) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2008.04.019 · Cited by 65
The interplay between bioactive sphingolipids and steroid hormones
Lucki, N. C., & Sewer, M. B. (2010) · Steroids · doi:10.1016/j.steroids.2010.01.020 · Cited by 67
“SPH is bound to the receptor under basal conditions and exchanged for PA, an SF-1-agonist [156], upon cAMP stimulation.”
Self-citationPhospholipid – Driven gene regulation
Musille, P. M., Kohn, J. A., & Ortlund, E. A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.004 · Cited by 51
“These data suggest a model, wherein SF-1 is maintained in an inactive conformation by sphingosine under basal conditions [65,67] and is activated by the binding of PA, which is generated subsequent to ACTH/cAMP signaling [66].”
BackgroundEscajadillo, T., Wang, H., LI, L. C., Li, D., & Sewer, M. B. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.03.006 · Cited by 46
“Immunostaining and microscopy were performed as described previously (Li et al., 2007).”
Self-citationJefcoate, C. R. E., Lee, J., Cherradi, N., Takemori, H., & Duan, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.006 · Cited by 41
“PKA can modify the SF-1 activity through effects on the enzymes that control the levels of these lipids, including ceramidase, sphingosine kinase and diglyceride kinase theta (Li et al., 2007).”
BackgroundPhospholipid regulation of the nuclear receptor superfamily
Crowder, M. K., Seacrist, C. D., & Blind, R. D. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.10.006 · Cited by 43
“Further, this interaction was shown to respond to cAMP signaling cascades, suggesting the interaction of a lipid metabolic enzyme (DAG kinase theta) and a nuclear receptor (SF-1), may be an important link between phospholipid metabolism and nuclear receptor regulation (Li et al., 2007).”
InfluentialThe BMP4-Smad signaling pathway regulates hyperandrogenism development in a female mouse model
Liu, Y., Du, S.-Y., Ding, M., Dou, X., Zhang, F., Wu, Z., Qian, S., Zhang, W., Tang, Q., & Xu, C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.781369 · Cited by 42
“However, expression of SF1, a known transcription factor of CYP17A1 and CYP19A1 (24), was not affected by BMP4 (Fig.”
BackgroundThe role of lipid second messengers in aldosterone synthesis and secretion
Spaulding, S. C., & Bollag, W. B. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100191 · Cited by 42
“PA has been demonstrated to be an endogenous activating ligand for SF-1 (79), with cAMP promoting the displacement of sphingosine (and SPC; see below) from and the binding of PA to the SF-1 ligand-binding pocket (112).”
BackgroundInfluentialComplex assembly on the human CYP17 promoter
Sewer, M. B., & Jagarlapudi, S. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.006 · Cited by 31
“Interestingly, nuclear recepor boxes are required for the interaction between diacylglycerol inase theta, the enzyme that produces phosphatidic acid, and SF(Li et al., 2007).”
BackgroundSelf-citationLucki, N. C., Li, D., Bandyopadhyay, S., Wang, E. L., Merrill, A. H., & Sewer, M. B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00378-12 · Cited by 31
“Our group has previously reported an NR-dependent interaction between SF-1 and DGK (36), the enzyme that produces the SF-1 agonist PA.”
BackgroundMethodResultSelf-citationBlind, R. D. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.015 · Cited by 29
“DGKθ interacts with SF-1 (Li et al., 2007) and DGKθ activity stimulates SF-1 gene expression programs in living cells (Cai and Sewer, 2013).”
BackgroundSteroidogenic Factor 1 and the Central Nervous System
Büdefeld, T., Tobet, S. A., & Majdič, G. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02174.x · Cited by 29
Cai, K., & Sewer, M. B. (2013) · Biochemical Journal · doi:10.1042/bj20130609 · Cited by 29
Self-citationBaldanzi, G., Pietronave, S., Locarno, D., Merlin, S., Porporato, P. E., Chianale, F., Filigheddu, N., Cantelmo, A. R., Albini, A., Graziani, A., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01953.x · Cited by 24
Cai, K., Lucki, N. C., & Sewer, M. B. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.12.005 · Cited by 24
Self-citationRole of phospholipases in adrenal steroidogenesis
Bollag, W. B. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0007 · Cited by 20
Bryant, J. M., Malabanan, M. M., Vanderloop, B. H., Nichols, C. M., Haratipour, Z., Poon, K. T., Sherrod, S. D., MCLEAN, J. A. J., & Blind, R. D. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100081 · Cited by 23
“the exclusion of other lipids (17, 18, 23), there are several”
BackgroundRelav, L., Doghman, M., Ruggiero, C., Muzzi, J. C. D., de Figueiredo, B. C., & Lalli, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043585 · Cited by 28
“Thereby, a cAMP-dependent mechanism has been thought to promote interactions between SF-1 and cofactors [85,87,88] and to induce the synthesis of activating ligands for SF-1 [89,90].”
BackgroundCai, K., & Sewer, M. B. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035634 · Cited by 18
Self-citationHozumi, Y., Akimoto, R., Suzuki, A., Otani, K., Watanabe, M., & Goto, K. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2199-3 · Cited by 17
Mérida, I., Ávila‐Flores, A., García, J., Merino, E., Almena, M., & Torres‐Ayuso, P. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.01.003 · Cited by 15
Braadland, P. R., Grytli, H. H., Ramberg, H., Katz, B., Kellman, R., Gauthier-Landry, L., Fazli, L., Krobert, K. A., Wang, W., Levy, F. O., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6479 · Cited by 16
“Furthermore, a number of target genes are common for the androgen and the PKA signaling cascades [13], and in steroidogenic cells both cAMP and PKA have been shown to regulate transcription of steroidogenic genes such as CYP17 and STAR [14-16], as well as to modulate their activity at the protein level [17].”
DGK-θ: Structure, Enzymology, and Physiological Roles
Tu‐Sekine, B., Goldschmidt, H. L., & Raben, D. M. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00101 · Cited by 13
“Knock down of DGK-θ, but not DGK-ζ, or expression of a kinase-dead mutant of DGK-θ abrogated agonist-induced expression of SF-1-mediated genes (Li et al., 2007).”
RORγt-Raftlin1 complex regulates the pathogenicity of Th17 cells and colonic inflammation
Singh, A. K., Kumar, R., Yin, J., Brooks, J. F., Kathania, M., Mukherjee, S. K., Kumar, J., Conlon, K. P., Basrur, V., Chen, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40622-1 · Cited by 12
Tu‐Sekine, B., & Raben, D. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21813 · Cited by 14
“A recent report revealed that the transcription factor SF-1 binds to DGK-u via two LXXLL motifs, one of which is contained within the C-terminal portion of the currently defined PH domain (Li et al., 2007).”
BackgroundInfluentialSanders, K., Mol, J. A., Slob, A., Kooistra, H. S., & Galac, S. (2017) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2017.11.001 · Cited by 8
Acidic Residue Glu199 Increases SUMOylation Level of Nuclear Hormone Receptor NR5A1
Wang, C., Liu, R., Wang, L., & Yang, W. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122331 · Cited by 7
“NR5A1 targets a variety of genes, including AMH [5], CYP17A1 [6], CYP19A1 [7], DGKθ [8], GnRHR [9], GSTA3 [10], MC2R [11], and STAR [12] in humans.”
BackgroundGuo, Y., Li, J., Miao, X., Wang, H., Ge, H., Xu, H., Wang, J., & Wang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123166 · Cited by 5
Balyura, M., Gelfgat, E., Ullmann, E., Ludwig, B., Barnea, E. R., & Bornstein, S. R. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-120064 · Cited by 4
“ACTH stimulation activates CYP17 transcription by promoting the binding of SF1 [21].”
BackgroundGuo, L., Wang, H. H., Yu, H. J., & Li, Q. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143551 · Cited by 4
Spaulding, S. C., Choudhary, V., & Bollag, W. B. (2023) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0196 · Cited by 3
Ripert, T., Crouzet, S., Ploussard, G., TAILLE, A. D. L., & Robert, G. (2013) · The French Journal of Urology · doi:10.1016/s1166-7087(13)70042-3 · Cited by 4
Cortisol-secreting adrenocortical tumours in dogs and their relevance for human medicine
Galac, S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.026 · Cited by 3
“A mechanism in which SF1 is activated by the binding of phosphatidic acid upon cAMP signalling has been suggested (Urs et al., 2006; Li et al., 2007).”
BackgroundDiacylglycerol kinases: Molecular mechanism of cellular and physiological functions
Kimura, T., & Epand, R. M. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101373 · Cited by 2
Functional Proteomics: Mapping Lipid-Protein Interactomes
D’Santos, C. S., & Aurlia, E. (2012) · InTech eBooks · doi:10.5772/30888 · Cited by 2
“Sewer and colleagues were able to identify several phospholipids bound to another orphan nuclear receptor, steroidogenic factor 1 (SF-1) (Li et al. 2007) with roles in the regulation of steroidogenic hormones expression.”
BackgroundNuclear Receptors, Chemistry of
Campbell, L. A., & Ingraham, H. A. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb402
Ehrlund, A. (2011) · Figshare
(2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283040e80
Campbell, A. N., & Blind, R. D. (2025) · Advances in Biological Regulation · doi:10.1016/j.jbior.2025.101131
“…any sphingolipid bound to SF-1 has been reported, despite strong mass spectrometry evidence suggesting sphingolipids specifically associate with SF-1, and can act as regulatory ligands (Li et al., 2007; Natasha C Lucki et al., 2012; N. C. Lucki et al., 2012; Ozbay et al., 2004; Urs et al., 2007).”
Metadata
- Authors
- Li, D., Urs, A. N., Allegood, J., Leon, A., Merrill, A. H., & Sewer, M. B.
- Affiliations
- Georgia Institute of Technology (US)
- Corresponding author
- Sewer, Marion B.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-10-01
- Volume
- 27
- Issue
- 19
- Pages
- 6669-6685
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2099220
- OpenAlex
- W2103290106
- Cited by
- 58
- References
- 120
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 2 · 2013: 9 · 2012: 3
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (0347682, CAREER)
- National Institutes of Health (GM073241, GM-069338)
- National Institute of General Medical Sciences (R56GM073241, U54GM069338, R01GM073241, GM 069338, GM073241)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- steroidogenic factor 1, cyclic AMP, CYP17, phosphatidic acid, ACTH, steroidogenesis, nuclear receptor coactivators, LXXLL motif, adrenal cortex, H295R cells
- MeSH terms
- Cyclic AMP, Adrenal Cortex, Adrenocorticotropic Hormone, Animals, Cell Line, Cell Nucleus, Enzyme Induction, Gene Expression Regulation, Humans, Isoenzymes, Phosphatidic Acids, Phospholipids, Promoter Regions, Genetic, RNA Polymerase II, Steroid 17-alpha-Hydroxylase, Signal Transduction, Genes, Reporter, Diacylglycerol Kinase, Two-Hybrid System Techniques, Steroidogenic Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.